Anthony Sinskey
Professor, Department of Biology; Co-Director, Malaysia-MIT Biotechnology Partnership Program Faculty; Director, MIT Center for Biomedical Innovation
Who they work with
Categories
Anthony J. Sinskey is a professor of microbiology in MIT’s Department of Biology, co-director of the Malaysia-MIT Biotechnology Partnership Program and faculty director of the MIT Center for Biomedical Innovation. He conducts interdisciplinary research in metabolic engineering focusing on the fundamental physiology, biochemistry and molecular genetics of important organisms. He is well known in the biopharmaceutical industry and has helped co-found several biotechnology companies, including Genzyme Corp., Natural Pharmaceuticals, Metabolix, Merrimack Pharmaceuticals, and Tepha. He has given more than 300 presentations at scientific meetings in the U.S. and abroad, and has received 31 issued patents and published more than 350 scientific papers in leading peer-reviewed journals for biology, metabolic engineering, and biopolymer engineering. He earned an ScD from MIT.
Publications
- Guttieres, D., Sinskey, A.J., Springs, S.L. (2021). Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2. Antibody Therapeutics.
- Guttieres, D., Sinskey, A.J., Springs, S.L. (2021). Modeling Framework to Evaluate Vaccine Strategies against the COVID-19 Pandemic. Systems, 9(1), 4.
- Li, C., Swofford, C. A., Sinskey, A. J. (2020). Modular engineering for microbial production of carotenoids. Metabolic Engineering Communications.
- Barone, P. W., Wiebe, M. E., Sinskey, A. J., Springs, S. L. et. al. (2020). Viral contamination in biologic manufacture and implications for emerging therapies. Nature Biotechnology 38, 563–572.
- Liu, Y., LJie, L. Z., Ma, X., Liang, H., Stephanopoulos, G., Sinskey, A. J., Zhou, K. (2020). Using biopolymer bodies for encapsulation of hydrophobic products in bacterium. Metabolic Engineering.